Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles

Bulletin of the World Health Organization

Volumn 77, Issue 11, 1999, Pages 923-928

  Bovet, P ^a   Yersin, C ^d   Herminie, P ^d   Lavanchy, D ^b   Frei, P C ^c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d NONE

Author keywords

Enzyme linked immunosorbent assay; Hepatitis B antibodies; Hepatitis C antibodies; Seychelles

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS C ANTIBODY;

DISEASE PREVALENCE; HEPATITIS; INFECTIOUS DISEASE;

ACADEMIC ACHIEVEMENT; ADULT; ALCOHOLISM; ANTIBODY TITER; ARTICLE; BLOOD DONOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; SCREENING TEST; SEROPREVALENCE; SEYCHELLES; VIRUS DIAGNOSIS; WESTERN BLOTTING;

AFRICA; AFRICA SOUTH OF THE SAHARA; ANTIBODIES; BIOLOGY; DEVELOPING COUNTRIES; DISEASES; EASTERN AFRICA; FRENCH SPEAKING AFRICA; HEPATITIS; IMMUNITY; IMMUNOLOGIC FACTORS; MEASUREMENT; PHYSIOLOGY; PREVALENCE; RESEARCH METHODOLOGY; RESEARCH REPORT; SAMPLING STUDIES; SEYCHELLES; STUDIES; SURVEYS; VIRAL DISEASES;

ADULT; AGE DISTRIBUTION; ALCOHOLISM; ENDEMIC DISEASES; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SEYCHELLES; SOCIOECONOMIC FACTORS;

SEYCHELLES;

EID: 0032805943     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cherubin CE et al. Acquisition of antibody to hepatitis B antigen in three socioeconomically different populations. Lancet, 1972, 2: 149-151.
2. Tsukuma H et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. New England journal of medicine, 1993, 328: 1797-1801.
3. Wong DKH et al. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a metaanalysis. Annals of internal medicine, 1993, 119: 312-323.
4. Dusheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Hepatology, 1995, 109: 908-916.
5. Expanded Programme on Immunization. Hepatitis B vaccine making global progress. Geneva, World Health Organization, 1996 (Expanded Programme on Immunization Update No. 31).
6. Hepatitis C. Weekly epidemiological record, 1997, 72 (10): 65-69.
7. Alter MJ et al. The prevalence of hepatitis C virus infection in the United States, 1988-1994. New England journal of medicine, 1999, 341: 556-562.
8. Choo QL et al. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. British medical bulletin, 1990, 46: 423-441.
9. Farci P et al. Lack of protective immunity against reinfection with hepatitis C virus. Science, 1992, 258: 135-140.
10. Alter MJ et al. The natural history of immunity-acquired hepatitis C in the United States. New England journal of medicine, 1992, 327: 1899-1907.
11. Davis GL et al. for the Hepatitis Interventional Therapy Group. Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. New England journal of medicine, 1998, 339: 1493-1499.
12. Nuti M et al. Seroepidemiology of infection with hepatitis A virus and hepatitis B virus in the Seychelles. American journal of epidemiology, 1982, 116: 161-167.
13. Bovet P et al. The Seychelles Heart Study II. Methods and selected basic findings. Seychelles medical and dental journal, 1997, 5: 8-24 (full text also available on www.seychelles.net/ smdj).
14. Werner GT. [Epidemiology of hepatitis A and B and yellow fever in Zaire.] Fortschritte der Medizin, 1984, 102 (40): 1019-1021 (in German).
15. Pawlotski JM et al. High prevalence of hepatitis B, C and E markers in young sexually active adults from the Central African Republic. Journal of medical virology, 1995, 46: 269-272.
16. Boisier P et al. Hepatitis B virus infection in general populations in Madagascar: evidence for different epidemiological patterns in urban and in rural areas. Epidemiology and infection, 1996, 117: 133-137.
17. Haukenes G et al. Hepatitis B virus markers in the population of Dar es Salaam, Tanzania. Journal of infection, 1987, 15: 183-188.
18. Chirom JP et al. [Markers of hepatitis B infection: detection of anti-HBc antibodies.] Nouvelle presse médicale, 1979, 8: 659-662 (in French).
19. Schwarz TF et al. Prevalence of antibodies against hepatitis A virus, hepatitis B virus and Treponema pallidum in Mauritius. Scandinavian journal of infectious diseases, 1991, 23: 535-541.
20. Bart PA et al. Seroprevalence of HBV (anti-HBc, HBsAg and anti-HBs) and HDV infections among 9006 women at delivery. Liver, 1996, 16: 110-116.
21. Struve J et al. Prevalence of hepatitis B virus markers in Sweden: a community-based serosurvey of 4000 young Swedish adults. American journal of epidemiology, 1992, 135: 409-417.
22. Garcia-Fulgueiras A et al. Prevalence of hepatitis B and C markers in the south-east of Spain: an unlinked community-based serosurvey of 2203 adults. Scandinavian journal of infectious diseases, 1996, 28: 17-20.
23. Lee WM. Hepatitis B virus infection. New England journal of medicine, 1997, 337: 1733-1745.
24. Aguelles O, Janot C. Epidemiology of anti-HCV antibodies in France: Viral hepatitis study. Archives of virology, 1992, 4 (Suppl.): 249-252.
25. El Gohary A et al. High prevalence of hepatitis C virus among urbar and rural population groups in Egypt. Acta tropica, 1995, 59: 155-161.
26. Zeller H et al. Prevalence of hepatitis C infection in the general population of Madagascar. Bulletin de la Société de Pathologie exotique, 1997, 90: 3-5.
27. Morvan JM et al. Serological markers for hepatitis A, B and C in Madagascar. First investigations in a rural area. Bulletin de la Société de Pathologie exotique, 1994, 87: 138-142.
28. Schwarz TF, Dobbler G, Gilch S. Hepatitis C and arboviral antibodies in the island populations of Mauritius and Rodrigues. Journal of medical virology, 1994, 44: 379-383.
29. Yap I et al. Seroprevalence of antibodies to the hepatitis C virus in Singapore. Southeast Asian journal of tropical medicine and public health, 1991, 22: 4581-4585.